title: Effects of rapamycin after syngeneic bone marrow transplantation in irradiated mice.
authors.affiliation: Sandoz Pharma Ltd, Basel, Switzerland.
authors.forename: V
authors.initials: V
authors.lastname: Quesniaux
authors.forename: H
authors.initials: H
authors.lastname: Gibbons
authors.forename: C
authors.initials: C
authors.lastname: Maurer
authors.forename: R
authors.initials: R
authors.lastname: Stirnimann
authors.forename: S
authors.initials: S
authors.lastname: Wehrli
mesh_terms: D000483:Alleles; D000818:Animals; D015415:Biomarkers; D001835:Body Weight / Q000187:drug effects / Q000528:radiation effects; D016026:Bone Marrow Transplantation / Q000276:immunology*; D002478:Cells, Cultured; D005260:Female; D005956:Glucose-6-Phosphate Isomerase / Q000096:biosynthesis / Q000235:genetics; D006410:Hematopoiesis / Q000187:drug effects* / Q000528:radiation effects; D006412:Hematopoietic Stem Cells / Q000166:cytology / Q000187:drug effects / Q000528:radiation effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D007375:Interleukin-1 / Q000494:pharmacology; D007377:Interleukin-3 / Q000494:pharmacology; D007958:Leukocyte Count / Q000187:drug effects / Q000528:radiation effects; D051379:Mice; D008810:Mice, Inbred C57BL; D010976:Platelet Count / Q000187:drug effects / Q000528:radiation effects; D011090:Polyenes / Q000494:pharmacology*; D011994:Recombinant Proteins / Q000494:pharmacology; D020123:Sirolimus; D014185:Transplantation, Isogeneic; D014916:Whole-Body Irradiation; D014965:X-Rays
chemical_list: D015415:Biomarkers; D007166:Immunosuppressive Agents; D007375:Interleukin-1; D007377:Interleukin-3; D011090:Polyenes; D011994:Recombinant Proteins; D005956:Glucose-6-Phosphate Isomerase; D020123:Sirolimus